Multiple Sclerosis Society UK logo
Program

MS Society UK Innovation Awards

Supports medical innovation groups in the United Kingdom with innovation innovation awards.

Multiple Sclerosis Society UKUnited KingdomGrant

The MS Society UK Innovation Awards sit under Multiple Sclerosis Society UK, the largest charitable funder of MS research in the UK. They back translational work that can make a direct difference for people affected by MS, especially projects that move therapeutics, diagnostics, or related innovations closer to use, including SME-led therapeutic discovery. The scheme is UK-based, annual, and grant-funded. Awards run from GBP 50,000 to GBP 300,000, with a typical working point around GBP 150,000, and the eligible stage is roughly TRL 2-5. For-profit applicants are required, UK researchers or companies are the intended audience, and the same project cannot be resubmitted for more support. Applications are reviewed by researchers and by people affected by MS, so scientific quality and patient relevance both matter. The strongest proposals are hypothesis-driven, clearly translational, and easy to defend as high-risk but practical steps toward a therapy, diagnostic, or another innovation with a visible path to impact.

Max award£300K
Realistic median£150K
Success rate20–30%
Decision time—

No upcoming rounds verified. Cadence: Annual.

Last verified: 11 May 2026Source: www.mssociety.org.uk